FDA Proposes E-Labeling Shift To “Structured Product Labeling” Format
Executive Summary
FDA is moving toward processing electronic submissions in a "structured product labeling" format rather than the portable document format (PDF), a draft guidance on e-labeling says
You may also be interested in...
FDA E-Labeling Rule Designed To Aid Drug Comparisons By Physicians, Patients
An FDA electronic labeling archive will help physicians and consumers make head-to-head comparisons between drugs, Commissioner McClellan said Dec. 9
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials